Pelvic organ prolapse (POP) affects millions of women, causing pain and diminished quality of life. Current options are limited, with surgery often the only choice. Lehigh University bioengineer Anand Ramamurthi, in collaboration with the Cleveland Clinic, has received NIH funding to develop a nonsurgical therapy using nanoparticles to regenerate pelvic tissue and slow or reverse POP progression.

A new editorial published in JMIR Medical Informatics examines the rapid rise of ambient artificial intelligence (AI) scribes—technologies designed to automate clinical documentation and ease the administrative burden on health care practitioners.

A Wits University research team has developed engineered TALENs—precision “molecular scissors”—that can permanently disable the genetic blueprint of the hepatitis B virus (HBV). The approach directly targets covalently closed circular DNA (cccDNA), the stubborn viral reservoir that current therapies cannot eliminate.

As a highlight of BIOHK2025—Asia's premier biotechnology conference and exhibition—Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, will partner with the Hong Kong Biotechnology Association to present a satellite forum themed "Exploring the Frontiers of AI in Drug Discovery, Development, and Beyond", entitled “Towards Pharmaceutical Superintelligence.”